Ventrix, Inc.: Clinical Trials

2 trials sponsored by Ventrix, Inc., newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 not yet recruiting. 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 12Completed 1, Not yet recruiting 1

Follow Ventrix, Inc.: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study of Intramyocardial Injection of Ventrix Bio Extracellular Matrix (VentriGel) to Assess the Safety and Feasibility in Pediatric Patients with Hypoplastic Left Heart Syndrome (HLHS)
Ventrix Bio Extracellular Matrix - Hypoplastic Left Heart Syndrome
Phase 1Not yet recruitingEmory University122025-08-012025-03-10
A Study of VentriGel in Post-MI Patients
VentriGel - Myocardial Infarction, Heart Failure
Phase 1CompletedVentrix, Inc.152015-09-012019-10-25

Conditions studied

Heart Failure (1)  ·  Hypoplastic Left Heart Syndrome (1)  ·  Myocardial Infarction (1)  ·  Ventricular Remodeling (1)

Countries

United States (2)

Top investigators

William Mahle, MD (1)